RETAKLIK (Retatrutide) 20mg

Research-Grade Retatrutide Formulation

RETAKLIK (Retatrutide) is a synthetic triple receptor agonist designed exclusively for in vitro and in vivo laboratory research applications. This compound demonstrates activity across GLP-1, GIP, and glucagon receptor pathways, making it suitable for investigative studies examining metabolic regulation, receptor signalling mechanisms, and physiological response modelling in controlled experimental environments.

Specification: 5mg/0.6mL concentration, 20mg total per vial

For Laboratory Research Use Only
Not for Human Consumption
Not for Medical, Therapeutic, Diagnostic or Veterinary Use
Handle in Accordance with Standard Laboratory Safety Protocols